Global Enoxaparin Sodium Market Growth 2023-2029

Global Enoxaparin Sodium Market Growth 2023-2029

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.
LPI (LP Information)' newest research report, the “Enoxaparin Sodium Industry Forecast” looks at past sales and reviews total world Enoxaparin Sodium sales in 2022, providing a comprehensive analysis by region and market sector of projected Enoxaparin Sodium sales for 2023 through 2029. With Enoxaparin Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enoxaparin Sodium industry.
This Insight Report provides a comprehensive analysis of the global Enoxaparin Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enoxaparin Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enoxaparin Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enoxaparin Sodium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enoxaparin Sodium.
The global Enoxaparin Sodium market size is projected to grow from US$ 2978.3 million in 2022 to US$ 5309.6 million in 2029; it is expected to grow at a CAGR of 5309.6 from 2023 to 2029.
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.
There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.
This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin Sodium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Teva
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Sandoz
Apotex
Hangzhou Jiuyuan Gene Engineering
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Suzhou Erye Pharmaceutical
Changzhou Qianhong Bio-pharma
Hebei Changshan Biochemical Pharmaceutical
Beijing SL Pharmaceutical
Huadong Medicine
Bharat Serums
INTAS
LUPIN
Troikaa Pharmaceuticals
Aristopharma
Fosun Pharma
SciencePharma
PISA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enoxaparin Sodium market?
What factors are driving Enoxaparin Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enoxaparin Sodium market opportunities vary by end market size?
How does Enoxaparin Sodium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.